Lupin gains on USFDA nod for generic Avapro tablets

Lupin Limited has moved higher by 2% at Rs 564 on the Bombay Stock Exchange after the company said that its subsidiary has received a final approval for its Irbesatan tablets from the United States Food and Drugs Administration (FDA) to market a generic …